The Book of Fungal Pathogens
Intro -- Contents -- Preface -- References -- Chapter 1 -- Fungal Diseases and COVID-19 -- Abstract -- Introduction -- Aspergillosis -- Mucormycosis -- Candidemia -- Conclusion -- References -- Chapter 2 -- New Aspect of Candida spp. Infections -- Abstract -- Introduction -- Virulence Factors and Candida Infections -- Adhesion -- Biofilm Formation -- Extracellular Hydrolytic Enzymes -- Polymorphism -- Antifungal Resistance -- Antifungals and Their Targets -- Azoles -- Polyenes -- Allylamines -- Morpholines -- Echinocandins -- 5-Flucytosine (5FC) -- Molecular Resistance Mechanisms of Candida spp. against Common Antifungal Drugs -- New Therapeutic Strategies -- Novel Drug and Delivery Systems in the Management of Candidiasis -- Colloidal Carriers -- Microemulsions -- Micelles -- Nano Emulsion -- Vesicular Carriers Liposomes -- Liposomes -- Nanoparticulate Carriers -- Nano Sponges -- Silver Nanoparticles -- Gold Nanoparticles -- Nanofibers -- Carbon Nanotubes -- Polymeric NPs -- Dendrimers -- New Therapeutic Agents against Fungal Infections -- Rezafungin -- Stage of Development and Clinical Studies -- Ibrexafungerp -- Stage of Development and Clinical Studies -- Fosmanogepix -- Stage of Development and Clinical Studies -- Nikkomycin Z -- Stage of Development and Clinical Studies -- Agents Targeting Cell Membrane VT-1129, VT-1161, and VT-1598 -- Stage of Development and Clinical Studies -- Encochleated Amphotericin B -- Stage of Development and Clinical Studies -- Natural Approaches to Candidiasis Probiotic and Candidiasis -- In vitro Antifungal Effects of Probiotics -- In vivo the Antifungal Effects of Probiotics -- Oral Candidiasis -- Urogenital Tract -- Gastrointestinal Tract -- Conclusion -- References -- Chapter 3 -- Pathogenesis of Oral Candidiasis: A Virulence Insight into Drug Discovery and New Treatments -- Abstract -- Introduction..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2022 ©2022 |
|---|---|
| Erschienen: |
New York: Nova Science Publishers, Incorporated ; 2022 ©2022 |
| Ausgabe: |
1st ed. |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
dos, Luis Souza [VerfasserIn] |
|---|
| Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Description based on publisher supplied metadata and other sources |
|---|
| Umfang: |
1 online resource (522 pages) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1830485709 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1830485709 | ||
| 003 | DE-627 | ||
| 005 | 20230427151620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230106s2022 xx |||||o 00| ||eng c | ||
| 020 | |a 9798886974706 |9 979-8-88697-470-6 | ||
| 035 | |a (DE-627)1830485709 | ||
| 035 | |a (DE-599)KEP083534164 | ||
| 035 | |a (EBC)EBC30301099 | ||
| 035 | |a (EBL)EBL30301099 | ||
| 035 | |a (EBP)083534164 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a dos, Luis Souza |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Book of Fungal Pathogens |
| 250 | |a 1st ed. | ||
| 264 | 1 | |a New York |b Nova Science Publishers, Incorporated |c 2022 | |
| 264 | 4 | |c ©2022 | |
| 300 | |a 1 online resource (522 pages) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Infectious Diseases and Microbiology Ser. | |
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a Intro -- Contents -- Preface -- References -- Chapter 1 -- Fungal Diseases and COVID-19 -- Abstract -- Introduction -- Aspergillosis -- Mucormycosis -- Candidemia -- Conclusion -- References -- Chapter 2 -- New Aspect of Candida spp. Infections -- Abstract -- Introduction -- Virulence Factors and Candida Infections -- Adhesion -- Biofilm Formation -- Extracellular Hydrolytic Enzymes -- Polymorphism -- Antifungal Resistance -- Antifungals and Their Targets -- Azoles -- Polyenes -- Allylamines -- Morpholines -- Echinocandins -- 5-Flucytosine (5FC) -- Molecular Resistance Mechanisms of Candida spp. against Common Antifungal Drugs -- New Therapeutic Strategies -- Novel Drug and Delivery Systems in the Management of Candidiasis -- Colloidal Carriers -- Microemulsions -- Micelles -- Nano Emulsion -- Vesicular Carriers Liposomes -- Liposomes -- Nanoparticulate Carriers -- Nano Sponges -- Silver Nanoparticles -- Gold Nanoparticles -- Nanofibers -- Carbon Nanotubes -- Polymeric NPs -- Dendrimers -- New Therapeutic Agents against Fungal Infections -- Rezafungin -- Stage of Development and Clinical Studies -- Ibrexafungerp -- Stage of Development and Clinical Studies -- Fosmanogepix -- Stage of Development and Clinical Studies -- Nikkomycin Z -- Stage of Development and Clinical Studies -- Agents Targeting Cell Membrane VT-1129, VT-1161, and VT-1598 -- Stage of Development and Clinical Studies -- Encochleated Amphotericin B -- Stage of Development and Clinical Studies -- Natural Approaches to Candidiasis Probiotic and Candidiasis -- In vitro Antifungal Effects of Probiotics -- In vivo the Antifungal Effects of Probiotics -- Oral Candidiasis -- Urogenital Tract -- Gastrointestinal Tract -- Conclusion -- References -- Chapter 3 -- Pathogenesis of Oral Candidiasis: A Virulence Insight into Drug Discovery and New Treatments -- Abstract -- Introduction. | ||
| 650 | 4 | |a Electronic books | |
| 776 | 1 | |z 9798886974546 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9798886974546 |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=30301099 |m X:EBC |x Aggregator |z lizenzpflichtig |
| 912 | |a ZDB-30-PQE | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a ISIL_DE-8 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a ISIL_DE-Brg3 | ||
| 912 | |a GBV_ILN_736 | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a ISIL_DE-289 | ||
| 951 | |a BO | ||
| 980 | |2 24 |1 01 |x 0008 |b 4250394514 |h olr-ddaebc |k Diesen Titel können Sie über den Zugriffslink zunächst für kurze Zeit nutzen (1 Campuszugriff zur Zeit möglich) und bei weiterem Bedarf nach persönlicher Registrierung auf der nachfolgenden Seite der Zentralbibliothek zur dauerhaften Anschaffung vorschlagen. Wir werden Sie zügig über die Bereitstellung informieren. |y z |z 21-01-23 | ||
| 980 | |2 206 |1 01 |x 3350 |b 4250496465 |c 00 |f --%%-- |d Online-Ressource |e g |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 21-01-23 | ||
| 980 | |2 736 |1 01 |x 4736 |b 4244827900 |h EBC-Content |y zeg |z 06-01-23 | ||
| 980 | |2 2021 |1 01 |x DE-289 |b 4250751384 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 23-01-23 | ||
| 981 | |2 24 |1 01 |x 0008 |r https://ebookcentral.proquest.com/lib/christianalbrechts/detail.action?docID=30301099 | ||
| 981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHf affiliates |r https://thh-friedensau.idm.oclc.org/login?url=http://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=30301099 | ||
| 981 | |2 736 |1 01 |x 4736 |r https://ebookcentral.proquest.com/lib/staat/detail.action?docID=30301099 | ||
| 981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=30301099 | ||
| 995 | |2 24 |1 01 |x 0008 |a olr-ddaebc | ||
| 995 | |2 206 |1 01 |x 3350 |a OLR-EBL | ||
| 995 | |2 736 |1 01 |x 4736 |a EBC-Content | ||